Temporarily controlled HIV-1 replication after intravenous immunoglobulin treatment of Guillain-Barré syndrome

Scandinavian Journal of Infectious Diseases

Volumn 37, Issue 11-12, 2005, Pages 877-881

  Gisslén, Magnus ^a,c   Fredman, Pam ^a   Fuchs, Dietmar ^b   Lekman, Annika ^a   Rosengren, Lars ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; IMMUNOGLOBULIN; LAMIVUDINE; NELFINAVIR; NEOPTERIN; SAQUINAVIR; STAVUDINE; SULFATIDE; VIRUS RNA;

ADULT; ARTICLE; BLOOD SAMPLING; CEREBROSPINAL FLUID; CLINICAL ARTICLE; DEMYELINATION; DISEASE SEVERITY; DRUG MEGADOSE; FOLLOW UP; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; VIRUS LOAD; VIRUS REPLICATION;

ADULT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; GUILLAIN-BARRE SYNDROME; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LYMPHOCYTE ACTIVATION; MALE; RNA, VIRAL; SULFOGLYCOSPHINGOLIPIDS; VIRUS REPLICATION;

EID: 30544441854     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540500277227     Document Type: Article

References (28)

1. Chun, TW Carruth, L Finzi, D Shen, X DiGiuseppe, JA Taylor, H et al. (1997) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection Nature, 387 183-8.
2. Siliciano, JD Kajdas, J Finzi, D Quinn, TC Chadwick, K Margolick, JB et al. (2003) Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T-cells Nat Med, 9, 727-8.
3. Wang, FX Xu, Y Sullivan, J Souder, E Argyris, EG Acheampong, EA et al. (2005) IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART J Clin Invest, 115, 128-37.
4. van Praag, RM Prins, JM Roos, MT Schellekens, PT Ten Berge, IJ Yong, SL et al. (2001) OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T-cell depletion J Clin Immunol, 21, 218-26 TH 3rd.
5. Brannagan, TH 3rd Zhou, Y. (2003) HIV-associated Guillain-Barré syndrome J Neurol Sci, 208, 39-42.
6. Hagberg, L Malmvall, BE Svennerholm, L Alestig, K Norkrans, G. (1986) Guillain-Barré syndrome as an early manifestation of HIV central nervous system infection Scand J Infect Dis, 18, 591-2.
7. Dwyer, JM. (1992) Manipulating the immune system with immune globulin N Engl J Med 326, 107-16.
8. Rhoades, CJ Williams, MA Kelsey, SM Newland, AC. (2000) Monocyte-macrophage system as targets for immunomodulation by intravenous immunoglobulin Blood Rev, 14, 14-30.
9. Bayry, J Thirion, M Misra, N Thorenoor, N Delignat, S Lacroix-Desmazes, S et al. (2003) Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases Neurol Sci, 24 (Suppl 4), S217-21.
10. Gisslen, M Fuchs, D Svennerholm, B Hagberg, L. (1999) Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection J Acquir Immune Defic Syndr, 21, 271-6.
11. Wirleitner, B Schroecksnadel, K Winkler, C Fuchs, D. (2005) Neopterin in HIV-1 infection Mol Immunol, 42, 183-94.
12. Gisslen, M Chiodi, F Fuchs, D Norkrans, G Svennerholm, B Wachter, H et al. (1994) Markers of immune stimulation in the cerebrospinal fluid during HIV infection: A longitudinal study Scand J Infect Dis, 26, 523-33.
13. Mildvan, D Spritzler, J Grossberg, SE Fahey, JL Johnston, DM Schock, BR et al. (2005) Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection Clin Infect Dis, 40, 853-8.
14. Fuchs, D Kramer, A Reibnegger, G Werner, ER Dierich, MP Goedert, JJ et al. (1991) Neopterin and beta 2-microglobulin as prognostic indices in human immunodeficiency virus type 1 infection Infection, 19 (Suppl 2), S98-102.
15. Abdulle, S Hagberg, L Svennerholm, B Fuchs, D Gisslen, M. (2002) Continuing intrathecal immunoactivation despite 2 y of effective antiretroviral therapy against HIV-1 infection Aids, 16, 2145-9.
16. Aukrust, P Muller, F Nordoy, I Haug, CJ Froland, SS. (1997) Modulation of lymphocyte and monocyte activity after intravenous immunoglobulin administration in vivo Clin Exp Immunol, 107, 50-6.
17. Bansil, S Mithen, FA Singhal, BS Cook, SD Rohowsky-Kochan, C. (1992) Elevated neopterin levels in Guillain-Barré syndrome. Further evidence of immune activation Arch Neurol, 49, 1277-80.
18. Rudzite, V Berzinsh, J Grivane, I Fuchs, D Baier-Bitterlich, G Wachter, H. (1996) Serum tryptophan, kynurenine, and neopterin in patients with Guillain-Barré-syndrome (GBS) and multiple sclerosis (MS) Adv Exp Med Biol, 398, 183-7.
19. Nettles, RE Kieffer, TL Kwon, P Monie, D Han, Y Parsons, T et al. (2005) Intermittent HIV-1 viraemia (Blips) and drug resistance in patients receiving HAART Jama, 293, 817-29.
20. Rosenberg, ES Altfeld, M Poon, SH Phillips, MN Wilkes, BM Eldridge, RL et al. (2000) Immune control of HIV-1 after early treatment of acute infection Nature, 407, 523-6.
21. Lisziewicz, J Rosenberg, E Lieberman, J Jessen, H Lopalco, L Siliciano, R et al. (1999) Control of HIV despite the discontinuation of antiretroviral therapy N Engl J Med, 340, 1683-4.
22. Garcia, F Plana, M Vidal, C Cruceta, A O'Brien, WA Pantaleo, G et al. (1999) Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy Aids, 13, F79-86.
23. Fischer, M Hafner, R Schneider, C Trkola, A Joos, B Joller, H et al. (2003) HIV RNA in plasma rebounds within d during structured treatment interruptions Aids, 17, 195-9. 195-9.
24. Davidsson, P Fredman, P Mansson, JE Svennerholm, L. (1991) Determination of gangliosides and sulfatides in human cerebrospinal fluid with a microimmunoaffinity technique Clin Chim Acta, 197, 105-15.
25. Fredman, P Vedeler, CA Nyland, H Aarli, JA Svennerholm, L. (1991) Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulfatide of peripheral nerve myelin J Neurol, 238, 75-9.
26. Fredman, P Wallin, A Blennow, K Davidss, P Gottfries, CG Svennerholm, L. (1992) Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia Acta Neurol Scand, 85, 103-6.
27. Tullberg, M Hultin, L Ekholm, S Mansson, JE Fredman, P Wikkelso, C. (2002) White matter changes in normal pressure hydrocephalus and Binswanger disease: Specificity, predictive value and correlations to axonal degeneration and demyelination Acta Neurol Scand, 105, 417-26.
28. Gisslen, M Fredman, P Norkrans, G Hagberg, L. (1996) Elevated cerebrospinal fluid sulfatide concentrations as a sign of increased metabolic turnover of myelin in HIV type I infection AIDS Res Hum Retroviruses, 12, 149-55.